Blood establishments are central to biotech innovation
EBA welcomes the European Commission’s proposal for a European Biotech Act. Public and non-profit blood establishments are the original precursors[…]
EBA suggests key improvements to Critical Medicines Act
The European Blood Alliance (EBA) welcomes the recent publication of the Critical Medicines Act (CMA) and believes it can have[…]
EBA concerned with rules on medical devices and in vitro diagnostics
The European Blood Alliance responded to the European Commission’s target evaluation of Regulations 2017/745 and 2017/746 on medical devices and[…]